» Authors » Miriam Jacob

Miriam Jacob

Explore the profile of Miriam Jacob including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 601
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Abadie B, Elghoul Y, Prakash S, Besir B, Ziada K, Jacob M, et al.
Eur Heart J Cardiovasc Imaging . 2025 Feb; PMID: 39919052
Background: Cardiac allograft vasculopathy (CAV) affects both epicardial and microvascular coronary arteries, however few studies have characterized microvascular dysfunction in this population. Several prior studies have shown positron emission tomography/computed...
2.
Borlaug B, Larive B, Frantz R, Hassoun P, Hemnes A, Horn E, et al.
Eur J Heart Fail . 2024 Jun; 26(7):1642-1651. PMID: 38837273
Aims: Patients with pulmonary hypertension (PH) are grouped based upon clinical and haemodynamic characteristics. Groups 2 (G2, left heart disease [LHD]) and 3 (G3, lung disease or hypoxaemia) are most...
3.
Mentias A, Desai M, Aminian A, Patel K, Keshvani N, Verma S, et al.
Circ Heart Fail . 2024 Jan; 17(2):e010453. PMID: 38275114
Background: Utilization patterns of bariatric surgery among older patients with heart failure (HF), and the associations with cardiovascular outcomes, are not well known. Methods: Medicare beneficiaries with HF and at...
4.
Abadie B, Albert C, Bhat P, Harb S, Jacob M, Starling R, et al.
Eur Heart J Cardiovasc Imaging . 2024 Jan; 25(6):814-820. PMID: 38214683
Aims: The short-term risk of moderate-severe cardiac allograft vasculopathy (CAV) after a low-risk positron emission tomography/computed tomography (PET/CT) is unknown, and therefore, there is no guidance on how frequently to...
5.
Naranjo M, Rosenzweig E, Hemnes A, Jacob M, Desai A, Hill N, et al.
Pulm Circ . 2023 Aug; 13(3):e12281. PMID: 37614830
The prevalence of acute vasodilator response (AVR) to inhaled nitric oxide (iNO) during right heart catheterization (RHC) is 12% in idiopathic pulmonary arterial hypertension (IPAH). AVR, however, is reportedly lower...
6.
Martens P, Yu S, Larive B, Borlaug B, Erzurum S, Farha S, et al.
Eur Heart J . 2023 Mar; 44(22):1979-1991. PMID: 36879444
Aims: Iron deficiency is common in pulmonary hypertension, but its clinical significance and optimal definition remain unclear. Methods And Results: Phenotypic data for 1028 patients enrolled in the Redefining Pulmonary...
7.
Longinow J, Buggey J, Jacob M, Martens P, Hanna M, Tang W, et al.
Am J Cardiol . 2023 Feb; 192:147-154. PMID: 36801551
Pulmonary hypertension (PH) portends a poor prognosis in chronic heart failure and within distinct cardiomyopathies. There is a paucity of data on the impact of PH in patients with light-chain...
8.
Martens P, Bhattacharya S, Longinow J, Ives L, Jacob M, Valent J, et al.
Circ Heart Fail . 2023 Jan; 16(3):e010078. PMID: 36695180
Background: Little information is available on the prognostic relevance of cardiac hemodynamic cutoffs in cardiac amyloidosis (CA) and its subtypes. Methods: Consecutive patients diagnose with light chain-CA or transthyretin CA...
9.
Abadie B, Chan N, Sharalaya Z, Bhat P, Harb S, Jacob M, et al.
JACC Heart Fail . 2023 Jan; 11(5):555-565. PMID: 36639302
Background: Invasive coronary angiography (ICA) is the traditional screening modality for cardiac allograft vasculopathy (CAV). Positron emission tomography/computed tomography (PET/CT) scan with myocardial blood flow (MBF) quantification has emerged as...
10.
Bradley E, Winchester D, Alfonso C, Carpenter A, Cohen M, Coleman D, et al.
Circulation . 2022 Sep; 146(16):e229-e241. PMID: 36120864
Academic medicine as a practice model provides unique benefits to society. Clinical care remains an important part of the academic mission; however, equally important are the educational and research missions....